Full Press Release Details
Alpha Healthcare Acquisition Corp. Announces Pricing of $100,000,000
Initial Public Offering
New York, NY, Sept. 17, 2020 (GLOBE
NEWSWIRE) - Alpha Healthcare Acquisition Corp. (the "Company") announced today that it priced its initial public
offering of 10,000,000 units at $10.00 per unit. The units will be listed on the Nasdaq Capital Market ("Nasdaq") and
will begin trading tomorrow, Friday, September 18, 2020, under the ticker symbol "AHACU". Each unit consists of one
share of the Company's Class A common stock and one-half of one redeemable warrant, each whole warrant entitling the holder
thereof to purchase one share of Class A common stock at a price of $11.50 per share. Only whole warrants are exercisable and will
trade. Once the securities comprising the units begin separate trading, shares of the Class A common stock and warrants are
expected to be listed on Nasdaq under the symbols "AHAC" and "AHACW," respectively.
The Company is a blank check company
formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar
business combination with one or more businesses. While the Company may pursue an initial business combination target in any business
or industry, it intends to focus its search on companies in the healthcare industry in the United States. The Company is led by
Chairman and Chief Executive Officer, Rajiv Shukla, and Chief Financial Officer, Patrick A. Sturgeon.
Oppenheimer & Co. Inc. is acting
as the sole book running manager for the offering and Northland Capital Markets is acting as co-manager for the offering. The Company
has granted the underwriters a 45-day option to purchase up to an additional 1,500,000 units at the initial public offering price
to cover over-allotments, if any.
The offering is being made only by
means of a prospectus. Copies of the prospectus may be obtained, when available, from Oppenheimer & Co. Inc., Attn: Syndicate
Prospectus Department, 85 Broad Street, 26th Floor, New York, New York 10004, by telephone at (212) 667-8055, by
fax at (212) 667-6140, or by email at EquityProspectus@opco.com.
A registration statement relating to
these securities has been filed with, and declared effective by, the Securities and Exchange Commission ("SEC") on
September 17, 2020. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor
shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be
unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Northland Capital Markets is the trade
name for certain capital markets and investment banking divisions of Northland Securities, Inc., Member FINRA and SIPC.
FORWARD-LOOKING STATEMENTS
This press release contains statements
that constitute "forward-looking statements," including with respect to the initial public offering. No assurance can
be given that the offering discussed above will be completed on the terms described, or at all. Forward-looking statements are
subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors
section of the Company's registration statement and preliminary prospectus for the offering filed with the SEC. Copies are
available on the SEC's website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions
or changes after the date of this release, except as required by law.
Alpha Healthcare Acquisition Corp.